Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Bayout case

<< Previous

Bullboard Posts

Next >>

Comment by Marcel49on Mar 17, 2023 9:58am

83 Views

Post# 35344709

RE:RE:RE:RE:RE:RE:RE:Bayout case

Une compagnie a l'obligation de rvler toute ngociation pour vendre ou de dvoiler une entente. Rien ne peut tre cach car a amnerait une enqute des autorits de surveillance. Mais certaines fins de sances o l'on fait planter le titre sur quelques centaines d'actions intrigue. Je ne comprend pas qu'aucune plainte ou enqute n'ait eu lieu.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price